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ABSTRACT
Malaria is an infectious disease caused by the parasite Plasmodium that is
transmitted by mosquitoes. It is estimated that malaria causes 1.1 million deaths
per year globally. While anti-malarial drugs have been effective in treating
infected individuals, new methodologies are needed. Treatments may benefit
from approaches that encapsulate drugs in vehicles allowing for more effective
delivery. To this end, the use of targeted drug delivery vehicles called filomicelles
to treat malaria is proposed.
Certain amphiphilic diblock copolymers self-assemble into filomicelles (long and
stable cylindrical micelles), which are capable of carrying hydrophobic drugs in
the bodies of rodents. It is shown in this dissertation that the surface of these
filomicelles can be covalently modified with peptides. The peptides have been
found by other research groups to bind apical membrane antigen 1 (AMA1) of
malaria parasites. AMA1 is part of the machinery that allows Plasmodium to
infect red blood cells.
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CHAPTER I
INTRODUCTION AND GENERAL INFORMATION
1.1 Significance
Malaria is an infection transmitted via mosquitoes carrying the causative
protozoan, Plasmodium. Much of the early work of the Centers for Disease
Control and Prevention (CDC), created in 1946, was to concentrate on the
control and elimination of malaria in the United States. With the successful
reduction of malaria in the United States, the CDC now focuses on malaria
prevention, surveillance, and technical support both domestically and
internationally. While no longer a major problem in the United States, malaria
infection remains a major threat to half of the world’s population. According to the
World Health Organization, between the years of 2000 and 2010 malaria caused
an estimate of 1.1 million deaths per year, inflicting both adults and children.
Current attempts in limiting the infection involve prophylactic treatments,
insecticides, environmental measures in eliminating the parasite-bearing
mosquitoes, and use of protective netting in shielding against mosquitoes.
However, drug resistance has become a major concern with the emergence of
both drug resistant mosquitoes and parasite. Chloroquine, for example, is an
anti-malarial drug used historically for malaria prophylaxis since the 1940s, but it
is no longer recommended by the CDC in travelers to many areas of the world
because the parasites have gained resistance to chloroquine [31]. Additionally,
other protective measures are not always practical or possible in other countries.
As a result, malaria remains a major global health issue. As of 2011, malaria is
endemic to more than 100 countries and territories.

1.2 Innovation
Drug delivery vehicles have shown promise in improving the treatments of
several diseases. I have developed a drug delivery vehicle based on the
template of filomicelles with the aim of improving the treatment of malaria.
Filomicelles are similar to worm-like micelles in their structure and
flexibility but are longer (lengths of microns as opposed to tens-of-nanometers)
and more stable [8]. They have a widely used poly(ethylene-oxide) (PEO)
surface chemistry that can be modified with cell-targeting peptides and can be
readily viewed with fluorescent microscopy. As a result of these unique physical
properties, filomicelles are emerging as alternate vehicles to more traditional
carriers such as liposomes.
Previous work on filomicelles focused on reducing the mass of epithelialbased tumors [6]. In that work, filomicelles were loaded with the anti-cancer drug
1

paclitaxel (TAX) and injected into mice bearing xenographs. The filomicelles
shrunk the size of the tumor over shorter carriers and freely circulating TAX.
In that study, the filomicelles were not targeted to the tumor – that is, no
biomolecules were conjugated to the exteriors of the filomicelles that had affinity
for the tumor cells. It was postulated that the filomicelles localized to the tumor
because of leaky vasculature characteristic of solid mass tumors [20].
Nanoparticles with modification for specific targeting have also been shown to be
new promising drug delivery approach [17,23].
The overall goal of this project will be to build upon these achievements by
targeting the filomicelles to the malaria parasite (P. yoelii 17XNL merozoites, a
rodent-specific species of Plasmodium). The first step of which is to conjugate
AMA1-binding peptides to the surfaces of the filomicelles.
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CHAPTER II
LITERATURE REVIEW AND BACKGROUND
This chapter includes reviews of articles on the two main topics of this
thesis: malaria and the class of drug delivery vehicles called filomicelles.

2.1 Malaria
2.1.1 Malaria Infection
Five strains of malaria parasites constitute major health risks: P. falciparum, P.
vivax, P. ovale, P. malariae, and P. knowlesi with P. falciparum being the most
pathogenic and accounting for most malarial mortality [5,18]. The parasites
exhibit a life cycle involving both an insect host and a vertebrate host. The sexual
stages develop in the female Anopheles mosquitoes and the asexual stages take
place in the mammalian host.
Identification of infection by P. falciparum is usually based on the presence of
small ring-stage parasites on blood smears [14]. Infected red blood cells are not
enlarged, and multiple infections of a single red blood cell are common [5]. An
important difference between P. falciparum and other human malarias is that
maturing trophozoites are usually sequestered in the capillaries of internal
organs, such as the heart, brain, spleen, skeletal muscles, and placenta, thus
protecting them from being cleared rapidly by the spleen [33]. Red blood cells
infected by P. vivax are enlarged and, when stained with Giemsa, often show
stippling on the red blood cell membrane, known as Schüffner’s dots [34]. All
stages of the P. vivax parasite are present in the peripheral circulation. P. ovale
infection produces a fever clinically similar to that of vivax malaria but somewhat
less severe. P. malariae develop in the mosquito slowly, and infection in humans
is not as intense as that caused by the other Plasmodium species [35]. Red
blood cells infected with P. malariae remain the same size throughout
schizozony. Infections by P. malariae and P. falciparum do not relapse. P.vivax
and P. ovale infections produce the classic relapsing malaria, initiated from
dormant parasites in the liver that have resumed development after a period of
latency [32].
Infected female mosquitoes transfer parasites into the subcutaneous tissue, and
less frequently directly into the blood stream, after a mosquito bite [19]. The
parasites are sporozoites (motile spore-like) at this stage of the infection, and
they localize to parenchymal cells of the liver. The sporozoites then invade liver
cells, where they replicate [30]. The length of this asexual division and the
number of non-motile progeny (merozoites) produced within each infected cell is
a characteristic of the individual species of Plasmodium. In general, over a period
3

of one to two weeks, the Plasmodium parasites produce and release thousands
of merozoites per liver cell. Specifically, P. falciparum, for example, produces
about 40,000 merozoites within one week. These merozoites then return to the
bloodstream and invade red blood cells. The mechanism of invasion involves
initial attachment of the parasite to the red blood cell, apical reorientation of the
merozoite, tight junction formation between host and parasite, apical organelle
secretion followed by host cell entry utilizing a moving junction between the
parasite and the host cell membrane, marked by erythrocyte deformation, and
then termination through resolution of ligand-receptor interactions by proteolytic
cleavage [21]. In the red blood cells, the parasite begins to grow, first forming the
ring-like early trophozoite, and eventually enlarging to fill the cell. The parasite
then undergoes asexual division and becomes a schizont composed of
merozoites. The parasites are nourished by the hemoglobin within the
erythrocytes and produce a characteristic pigment called hemazoin. The cycle is
completed when the red blood cell ruptures and releases newly formed
merozoites into the bloodstream, leading to clinical infection.
Many attempts to stop invasion have involved targeting merozoite surface
proteins. The merozoite surface proteins are very diverse and polymorphic. Of
these surface proteins, apical membrane antigen 1 (AMA1) has been identified
as an essential gene for parasite invasion and survival within the human host
[15]. I focus on targeting this protein.
2.1.2 Apical Membrane Antigen 1
Apical membrane antigen 1 (AMA1) of Plasmodium is a surface protein that is
expressed in schizont-stage malaria parasite, sporozoites, and merozoites, and
plays a crucial role in the invasion of both hepatocytes and red blood cells
[12,24].
Several peptides have been identified to bind to AMA1. These peptides include
[10]:
1. R1 (VFAEFLPLFSKFGSRMHILK)
2. R3 (PVLRSGRCAELIQIGFRCRA)
3. F1 (GWRLLGFGPASSFSM)
Although AMA1 itself is also very polymorphic, it contains a conserved
hydrophobic trough that all three peptides appear to bind [11], blocking merozoite
invasion, even after initial attachment to the red blood cell surface [16,26]. In a
study with multiple sequence alignment of the AMA1 amino acid sequences from
six Plasmodium species (P. berghei, P. yoelii, P. chabaudi, P. vivax, P. knowlesi,
and P. falciparum), 60% of the residues in this region of the protein are
conserved across the Plasmodium species including P. yoelii [1,12]. Therefore,
these peptides are attractive candidates for targeting Plasmodium to reduce red
blood cell invasion.
4

2.2 Filomicelles
In this study, I propose to modify the surface chemistry of filomicelles with
peptides that have been identified to bind malaria parasites. The long-term goal
is to hamper the life cycle of malaria parasites by administering these
functionalized filomicelles to mice infected with parasites. By functionalizing
filomicelles with the above peptides, I aim to achieve specific targeting and retain
the previous benefits of delivering hydrophobic drugs. The filomicelles used here
have lengths of several microns and diameters of about fifty nanometers [4,27].
The flexibilities of the filomicelles are on the order of the diameter of malaria
parasites. The most desirable strength of these fluid filomicelles is that they
remain in the circulation of rodents ten-fold longer than spherical analogs and are
more persistent than any known synthetic nanoparticle [6], providing an extended
opportunity to bind circulating Plasmodium parasites.
2.2.1 Degradable Filomicelles
Filomicelles prepared from poly(ethylene oxide) - poly(ε-caprolactone)copolymers (PEO-PCL) spontaneously shorten to generate spherical micelles
due to chain-end hydrolysis of the caprolactone [7]. This characteristic can be
used in controlled drug release [28].
2.2.2 Non-degradable Filomicelles
Filomicelles prepared from non-degradable amphiphilic poly(ethylene oxide) poly(butadiene) copolymers (PEO-PBD) are stable for years at 4C and can stay
in circulation longer than spherical analogs [6], providing an extended opportunity
to bind and engulf Plasmodium parasites. Both degradable and non-degradable
filomicelles may prove effective at different times during the malaria parasite life
cycle in infected animals.
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CHAPTER III
MATERIALS AND METHODS
3.1 Modified Filomicelles
3.1.1 Filomicelles
The filomicelles used here were assembled from diblock copolymers of polyethylene oxide (PEO) with either poly-caprolactone (PCL) or poly-butadiene
(PBD) as the hydrophobic block. PEO is FDA-approved for use in the body and
PCL is biodegradable. PCL and PBD provide the structural stability of the
filomicelles and PEO keeps the filomicelles soluble in aqueous environments.
The PEO can also be modified for peptide attachment.
In the beginning stages of my thesis, I perfected and scaled up the formation of
PEO-PCL filomicelles. I am now able to obtain 50 ml’s of PEO-PCL filomicelles
whereas before I had 1 ml of PEO-PCL filomicelles with many assembles that
were not cylindrical.
The following procedure was used to form filomicelles having parasite binding
peptides. COOH-PEO-PBD was mixed with PEO-PCL where the carboxyl groups
were exposed to the aqueous environment. The carboxyl groups react with 1ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC) to form an
unstable reactive ester intermediate (Figure 1). N-hydroxysulfosuccinimde (SulfoNHS) and the peptide are then added to the reaction to form a filomicelle where a
certain fraction of the COOH-PEO-PBD diblock copolymers have the new
chemistry, peptide-CO-PEO-PBD [9].

Figure 1. Schematic Diagram for Attaching Primary Amines to PEG.
The symbol * on *PEO-PBD indicates where the carboxylate is located.
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3.1.2 AMA1-Targetting Peptides
Three peptides have been identified that bind AMA1 [10]. Of the three, R1
contains lysine, which has the potential to form side products in our reaction
scheme, which could reduce its affinity for AMA1 [11,13]. Therefore, I focused on
conjugating R3 and F1 peptides to the exteriors of the filomicelles.
3.1.3 Visualization Method
Filomicelles were visualized by fluorescent microscopy using a hydrophobic dye
(PKH26) [2,3]. After formation of the filomicelles, 1 μL of 1 mM PKH26 dye in
ethanol was added to a 1 mg/ml sample of PEO-PCL filomicelles. Since the dye
is hydrophobic, it partitions into the cores of the filomicelles. PKH26 dye remains
in the cores of non-degradable PEO-PBD filomicelles for up to one week in the
plasma of rodents after tail-vein injection.
3.1.4 Bovine Serum Albumin
Before working with the above peptides, I wished to attach a readily available
biomolecule to the filomicelles. Bovine serum albumin (BSA) was chosen
because it has multiple exposed lysines and is inexpensive. I attached BSA to
the filomicelles using the method described in section 3.1.1. Coomassie staining
was used to quantify the amount of BSA bound to the filomicelles.
3.1.5 Electrophoresis
Analysis of SDS-page gels was used to show covalent binding of F1 peptide to
the COOH-PEO-PBD copolymer.
3.1.6 Fluorescence Microscopy and Spectroscopy with Alexa Fluor
To determine attachment of R3 to the filomicelles, cysteines on R3 were labeled
with a fluorescent maleimide molecule. The fluorescence of the samples was
measured after unbound peptides were removed by dialysis.

7

3.2 PEO-PCL Filomicelle Degradation
3.2.1 Scanning Transmission Electron Microscopy (STEM)
A major question in the field of drug delivery is how the structural integrity of drug
delivery vehicles is affected by the deposition of plasma proteins on the surface
of the vehicles. To help address this question, I monitored the morphology
changes of filomicelles in aqueous media and then in the presence of serum
proteins.
Negative staining is a qualitative method for examining the structure of isolated
organelles, individual macromolecules and viruses at the nano scale. Here, I
imaged filomicelles using negative staining under an electron microscope.
Observation of differences on the surface and in shape from degradation was
made to qualitatively determine stability of the filomicelles. Since PCL degrades
over time, an aging study on the PEO-PCL filomicelles was conducted and the
morphology changes of the filomicelles, possibly due to hydrolysis [7], were
observed. PEO-PBD filomicelles were used as a control.
3.2.2 Chromatography
Ion-exchange chromatography was used in the separation of filomicelles and
proteins contents introduced in the studying of filomicelle stability in presence of
high protein environment. Source Q resin was used to separate filomicelles and
preliminary tests are done using bovine serum albumin (BSA) in solution.
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CHAPTER IV
RESULTS AND DISCUSSION
This chapter includes the results and discussion from the experiments
where filomicelles were modified with a test protein, bovine serum albumin
(BSA), and then with AMA1-binding peptides, R3 and F1 (section 4.1). Also
included are the in vitro experiments studying PEO-PCL and PEO-PBD stability
using STEM (section 4.2).

4.1 Modified Filomicelles
The chemicals EDC and Sulfo-NHS were used to modify the carboxylic
acid ends of the COOH-PEO-PBD copolymers so that the primary amine of a
peptide could form a stable covalent bond to the filomicelle. This chemistry is
used widely in immobilization procedures and immunogen preparation (attaching
a small peptide to a large carrier protein). Several experiments were carried out
to test for stable attachment. The morphology of the modified filomicelles was
also observed in select cases.
4.1.1 Bovine Serum Albumin (BSA) attachment to filomicelles
BSA was attached to filomicelles using the chemistry scheme shown in Figure 1.
Two filomicelle samples were formed. In both samples, 99% of the copolymers
were PEO-PCL and 1% were COOH-PEO-PCL. For the first sample, the above
chemistry scheme was used to attach BSA through its N-terminus or lysine
groups. For the second sample, only BSA was added and EDC and Sulfo-NHS
were omitted.
Both samples were stained with Bradford and showed comparable signals
(Figure 2). BSA that had not bound the filomicelles was then removed by dialysis
overnight. The Bradford signal of the second sample was reduced by a factor of
four and was much lower than the signal of the first sample (Figure 2). This
suggests that BSA was covalently attached to the modified carboxyl group on the
end of the COOH-PEO-PBD copolymer.
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Figure 2. Attachment of BSA to filomicelles.
Modified filomicelles with BSA attachments before dialysis (A), modified filomicelles with
BSA attachments after dialysis (B), regular filomicelles with BSA in solution before
dialysis (C), and regular filomicelles after dialysis (D). The dashed boxes show 95%
confidence interval.

4.1.2 Modified Filomicelles with R3 and F1 peptides
Unfortunately, using Bradford or equivalent stains to determine whether
biomolecules are present on filomicelles was unsuccessful because the signal to
noise ratio is too low to be detected by spectrophotometers. To overcome this
issue, SDS-Page gels were used to determine whether covalent peptide
attachment to filomicelles was successful. After performing the chemistry scheme
shown in Figure 1 with the F1 peptide, the products were run on an SDS-page
gel. The band for unbound peptide can be seen in lane 1; two bands can be seen
in lane 2; and a light but broad band can be seen in lane 3 (Figure 3). I postulate
that the lower band in lane 2 is peptide conjugated to copolymer and the upper
band in lane 2 represents filomicelles that have peptide bound but have not
broken up completely. It is not yet understood why the filomicelles appear in lane
3 because they are not charged.
An additional technique that can be used to determine if biomolecules have
bound filomicelles is to label the biomolecules with a fluorescent probe.
Fluorescent maleimide molecules can be used for this purpose if the
biomolecules have solvent-exposed cysteines. I used this scheme to determine if
R3 peptide (PVLRSGRCAELIQIGFRCRA), which contains two cysteines, was
covalently attached to the filomicelles after using the chemistry scheme of Figure
10

1. After formation of two sets of filomicelles with 0.1% COOH-PEO-PBD and
99.9% PEO-PCL, the chemistry scheme described in Figure 1 was used to
attach R3 to the modified COOH in the first set of filomicelles. EDC and sulfoNHS were not added to the second set of filomicelles. A fluorescent maleimide
(λ=556) was introduced to both samples. The first set of filomicelles had a 2-fold
increase in fluorescence over the control. Fluorescent microscopy images reveal
similar results (Figure 4).
It is not clear why the difference in fluorescence between the two samples was
so low. One possibility is that the modified COOH group is not well exposed on
the PEO brush because the COOH-PEO group is shorter than the PEO group on
the other 99.9% of the copolymers. Graduate student Kevin Quigley is currently
attempting modify longer PEO groups to PEO-COOH.

Figure 3. SDS-Page gel
showing F1 peptide
Attachment.
Ladder, F1 peptide, modified
filomicelles with F1 peptide,
and regular filomicelles.

Figure 4. Fluorescent microscopy images showing
R3 peptide Attachment.
Filomicelles with R3 covalently bound to the COOHPEO-PBD groups were incubated with Alexa Fluor
maleimide, which binds the cysteines of R3. (A-C)
Fluorescent micrographs of (A) R3-filomicelles after
incubation with the reactive fluorophore, (B) same as
(A) but with PKH26 dye added, (C) Unreactive
filomicelles after incubation with the reactive
fluorophore (control for (A)), and (D) same as (B) but
with unreactive filomicelles.
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4.2 Filomicelles as a Model System to Study Drug Delivery
Vehicle Degradation
4.2.1 Filomicelle Aging Study
For a drug delivery vehicle to be effective it must maintain its structural integrity
in the body. Vehicles that fall apart and leak their contents before reaching the
target area in the body are of limited efficacy and can cause side effects. To
address this issue, the morphology changes of filomicelles over time were
observed using electron microscopy. Electron micrographs showed
morphological changes in areas that were degrading presumably due to
hydrolysis of the PCL in the filomicelle (Figure 5). Over time, hydrolysis continues
to shorten the PCL to the extent that the copolymer then favors spherical
conformation [7], which results in the disappearance of cylindrical micelles and
appearance of many spherical micelles in the sample by day eleven.

Figure 5. PEO-PCL Filomicelles Degradation.
Filomicelles are represented with blue hydrophilic regions and red hydrophobic regions.
The yellow spheres represent dye or drug molecules that can be embedded for delivery.
The life of PEO-PCL filomicelles starts with filomicelles with smooth contour (day 1 or
t=0 hours). By day 5, t=96 hours, most of the filomicelles show dark areas surrounding
edges and corners, which would be the means for the drug (yellow spheres), embedded
to leave the carrier. By day 11, t=240 hours, most of the filomicelles have disappeared,
leaving spherical micelles.
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4.2.2 Accelerated Degradation in High BSA Concentration
I ultimately wish to determine rates of filomicelle morphological changes in
physiologically relevant situations. To this end, I incubated filomicelles with
serum proteins. Two sets of filomicelles were formed: one set was incubated in
20 mM Tris-HCl buffer, and a second set was incubated in the same buffer with
0.05 mM BSA. Samples were run through Source Q resin to remove unbound
proteins (the worms flow past the beads and do not bind). This was done to clear
the samples of large proteins, which complicate electron micrograph
interpretation. Comparing the two sets of samples suggests that presence of
BSA accelerates rate of filomicelle aging by day 3, t=48 hours (Figure 6). The
sample with BSA resembles the disappearance of cylindrical micelles and
appearance of many spherical micelles in the sample by day eleven from the
previous study in water. This implies that the morphology change of the
filomicelles would be accelerated when injected and tested in vivo; therefore,
more studies to determine the effects of protein deposition and shear on
filomicelle morphology and stability is needed to prevent premature release of
loaded drugs in these degradable micelles.

Figure 6. Day 3 PEO-PCL filomicelles in 20 mM Tris-HCl and BSA
Filomicelles in 20 mM Tris-HCl buffer (left pannel). Filomicelles in the presence of 0.05
mM BSA in 20 mM Tris-HCl buffer (right panel).
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CHAPTER V
CONCLUSIONS AND RECOMMENDATIONS
My thesis focused on optimizing the covalent conjugation peptides to the
exteriors of filomicelles. The peptides were previously identified to bind apical
membrane antigen 1 (AMA1), which is expressed on the surface of malaria
parasites. I also used high-resolution microscopy techniques to determine
changes in filomicelle morphology over time in aqueous media and with the
addition of serum proteins.
BSA, R3, and F1 peptides were reacted with the filomicelles and their
attachment was checked with Bradford, SDS-Page, and cysteine-maleimide
chemistry.
In the second project, electron micrographs of aging PEO-PCL filomicelles
reveal unraveling and multi-location degradation over several days in water.
Electron micrographs of PEO-PCL filomicelles incubated with BSA concentration
shows higher degradation rate, but similar degradation pattern. In the future, this
study will extend to monitoring filomicelle structure in plasma and finally live
animals.
Two in vivo experiments in the Schmidt Lab are proposed for future testing
the effectiveness of R3- and F1-filomicelles in the mouse model of the disease.
The first is to mix the filomicelles with infected red blood cells (iRBC) and coinject this mixture into C57BL/6 mice. If the number of parasites is reduced in
subsequent blood samples, it will show that filomicelles may be effective in
blocking the parasites’ replication cycle. The second experiment will be to inject
filomicelles into mice that are already infected with the parasite. Again, the
number of parasites in circulation will be quantified to determine if filomicelles are
appropriate for reducing their replication. In both cases I am hoping for binding of
filomicelles to the parasites through the R3-AMA1 and F1-AMA1 interactions
(Figure 7).

14

Figure 7. Mechanism of binding malaria parasites by modified filomicelles
The more stable PEO-PBD filomicelles, are expected to bind and ensnare the merozoite
(A), and the degradable PEO-PCL filomicelles can be loaded with anti-malarial drugs,
and are expected to breakdown and release the drugs (shown in yellow) after localizing
near the parasite. These are future projects that were not explored in this work (B).
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Appendix I. Electron Micrographs of PEO-PCL Hydrolysis in vitro
Each of the samples has been examined as described in section 3.2.1. “Day 1
samples” refer to the samples examined on the day the filomicelles were formed,
thus are also samples at t=0 hours. “Day 3 samples” refer to the samples
examined on the third day after the filomicelles were formed, thus are also
samples at t=48 hours, and so on.

Figure 8. Electron micrographs of PEO-PCL filomicelles in water on day 1.
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Figure 9. Electron micrographs of PEO-PCL filomicelles in water on day 3.

Figure 10. Electron micrographs of PEO-PCL filomicelles in water on day 5.
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Figure 11. Electron micrographs of PEO-PCL filomicelles in water on day 7.

Figure 12. Electron micrographs of PEO-PCL filomicelles in water on day 9.
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Figure 13. Electron micrographs of PEO-PCL filomicelles in water on day 11.
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Figure 14. Electron micrograph of PEO-PCL filomicelles in water on day 11.
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Appendix II. Supporting Data

Table 1. Protein Bradford Data
Protein Bradford with BSA Data
Sample
1
2
3
4
5
6
7
8
9
10
Mean

With/Before With/After Without/Before Without/After
0.019
0.014
0.020
0.000
0.020
0.015
0.016
0.001
0.018
0.015
0.017
0.003
0.019
0.016
0.015
0.002
0.018
0.013
0.018
0.000
0.017
0.012
0.019
0.001
0.017
0.016
0.017
0.001
0.018
0.017
0.016
0.002
0.017
0.014
0.019
0.002
0.018
0.013
0.020
0.003
0.018

0.015

0.018

Table 2. PCL Filomicelle (Worm) Experiment with Alexa Fluor.

Sample
worm with peptide and fluor
plain worm with fluor (control)

Abs
0.296
0.156

no PKH 26
(worms/
5000 μm2)
1.92
0

26

with PKH
26
(worms/
5000 μm2)
2.25
2.1

0.002
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